We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
276
ImmunityBio
IBRX
$8.2B
$378K 0.04%
147,754
+13,788
+10% +$57.4K
CDW icon
277
CDW
CDW
$17.1B
$377K 0.04%
2,169
+475
+28% +$92.3K
MNKD icon
278
MannKind Corp
MNKD
$1.24B
$376K 0.04%
58,475
+5,585
+11% +$37.4K
NMRA icon
279
Neumora Therapeutics
NMRA
$317M
$363K 0.03%
+34,257
New +$411K
INDV icon
280
Indivior Pharmaceuticals
INDV
$4.57B
$359K 0.03%
+28,906
New +$297K
DVAX
281
DELISTED
Dynavax Technologies
DVAX
$356K 0.03%
27,873
+2,669
+11% +$32.3K
FTRE icon
282
Fortrea Holdings
FTRE
$1.74B
$355K 0.03%
19,020
+1,787
+10% +$34.8K
ARQT icon
283
Arcutis Biotherapeutics
ARQT
$3.3B
$346K 0.03%
24,818
+2,336
+10% +$25.6K
GPCR icon
284
Structure Therapeutics
GPCR
$3.83B
$343K 0.03%
12,634
+1,174
+10% +$41.7K
XNCR icon
285
Xencor
XNCR
$1.72B
$341K 0.03%
14,839
+2,946
+25% +$67.7K
ZK
286
DELISTED
Zeekr
ZK
$341K 0.03%
+12,000
New +$306K
AFRM icon
287
Affirm
AFRM
$24.6B
$338K 0.03%
+5,547
New +$308K
SPY icon
288
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$335K 0.03%
570
+350
+159% +$206K
BCRX icon
289
BioCryst Pharmaceuticals
BCRX
$2.71B
$330K 0.03%
43,920
+4,129
+10% +$31.3K
TXG icon
290
10x Genomics
TXG
$7.52B
$326K 0.03%
+22,687
New +$358K
AZO icon
291
AutoZone
AZO
$49.7B
$320K 0.03%
100
-50
-33% -$158K
TVTX icon
292
Travere Therapeutics
TVTX
$5.86B
$317K 0.03%
18,206
+3,494
+24% +$61.8K
CNTA
293
DELISTED
Centessa Pharmaceuticals
CNTA
$317K 0.03%
18,909
+5,316
+39% +$88.1K
PRAX icon
294
Praxis Precision Medicines
PRAX
$10.8B
$304K 0.03%
+3,952
New +$286K
INSP icon
295
Inspire Medical Systems
INSP
$1.68B
$292K 0.03%
+1,574
New +$306K
HMY icon
296
Harmony Gold Mining
HMY
$12.4B
$291K 0.03%
35,400
– –
ZLAB icon
297
Zai Lab
ZLAB
$2.86B
$290K 0.03%
11,061
+1,502
+16% +$41.7K
SYRE icon
298
Spyre Therapeutics
SYRE
$9.18B
$290K 0.03%
+12,440
New +$365K
OCUL icon
299
Ocular Therapeutix
OCUL
$2.25B
$285K 0.03%
33,336
+3,347
+11% +$32.7K
NRIX icon
300
Nurix Therapeutics
NRIX
$2.76B
$283K 0.03%
15,020
+2,632
+21% +$60.3K
10 11
12
13 14

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.